REDWOOD CITY, Calif., Jan. 5, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, will present at the J.P. Morgan 28th Annual Healthcare Conference on Thursday, January 14, at 1:00 p.m. Pacific Time. The conference will take place at the Westin St. Francis in San Francisco. Dr. Selick will provide an overview of Threshold and its clinical development program for TH-302, a novel drug candidate for the potential treatment of solid tumors.
